PlainRecalls
FDA Drug Moderate Class II Terminated

Venlafaxine Hydrochloride Extended-Release Capsules USP, 75 mg, packaged in a) 30-count bottles (NDC 52343-132-30) and b) 90-count bottles (NDC 52343-132-90), Rx only, Distributed by: Lucid Pharma LLC, 2 Tower Center Blvd, Suite-1101-B, East Brunswick, NJ 08816 USA.

Reported: June 28, 2017 Initiated: June 1, 2017 #D-0921-2017

Product Description

Venlafaxine Hydrochloride Extended-Release Capsules USP, 75 mg, packaged in a) 30-count bottles (NDC 52343-132-30) and b) 90-count bottles (NDC 52343-132-90), Rx only, Distributed by: Lucid Pharma LLC, 2 Tower Center Blvd, Suite-1101-B, East Brunswick, NJ 08816 USA.

Reason for Recall

Failed Tablet/Capsules Specifications: pharmacists complaints for bottles containing melted capsules.

Details

Recalling Firm
Lucid Pharma LLC
Units Affected
a) 44168 bottles; b) 24960 bottles
Distribution
Nationwide in the USA
Location
East Brunswick, NJ

Frequently Asked Questions

What product was recalled?
Venlafaxine Hydrochloride Extended-Release Capsules USP, 75 mg, packaged in a) 30-count bottles (NDC 52343-132-30) and b) 90-count bottles (NDC 52343-132-90), Rx only, Distributed by: Lucid Pharma LLC, 2 Tower Center Blvd, Suite-1101-B, East Brunswick, NJ 08816 USA.. Recalled by Lucid Pharma LLC. Units affected: a) 44168 bottles; b) 24960 bottles.
Why was this product recalled?
Failed Tablet/Capsules Specifications: pharmacists complaints for bottles containing melted capsules.
Which agency issued this recall?
This recall was issued by the FDA Drug on June 28, 2017. Severity: Moderate. Recall number: D-0921-2017.